Basics Vivos Therapeutics, Inc. IPO Date: July 7, 2020 Sector: Healthcare Industry: Medical Devices Market Cap: $18.61M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 5.05% Avg Daily Range (30 D): $0.09 | 3.66% Avg Daily Range (90 D): $0.14 | 4.05% Institutional Daily Volume Avg Daily Volume: .84M Avg Daily Volume (30 D): .11M Avg Daily Volume (90 D): .2M Trade Size Avg Trade Size (Sh.): 235 Avg Trade Size (Sh.) (30 D): 188 Avg Trade Size (Sh.) (90 D): 150 Institutional Trades Total Inst.Trades: 25 Avg Inst. Trade: $.96M Avg Inst. Trade (30 D): $.65M Avg Inst. Trade (90 D): $.65M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $1.05M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $.84M Avg Closing Volume: 12.46K     News Aug 20, 2025 @ 8:24 PM Vivos Reports 7% Sales Drop Source: Jesterai Jun 27, 2024 @ 11:30 AM Vivos Therapeutics Announces Positive Results From... Source: Vivos Therapeutics, Inc Jun 12, 2024 @ 11:30 AM Vivos Therapeutics Closes $7.5 Million At-The-Mark... Source: Vivos Therapeutics, Inc May 14, 2024 @ 11:30 AM Vivos Therapeutics Schedules Release of First Quar... Source: Vivos Therapeutics, Inc Apr 9, 2024 @ 11:30 AM Vivos Therapeutics’ Flagship CARE Oral Medi... Source: Vivos Therapeutics, Inc Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.77 $-.49 $-.55 Diluted EPS $-1.77 $-.49 $-.55 Revenue $ 17.32M $ 6.78M $ 3.82M Gross Profit $ 9.65M $ 3.94M $ 2.11M Net Income / Loss $ -17.1M $ -5.4M $ -5.01M Operating Income / Loss $ -16.32M $ -4.73M $ -4.87M Cost of Revenue $ 7.67M $ 2.85M $ 1.71M Net Cash Flow $ -3.22M $ -1.32M $ -1.86M PE Ratio     Splits Oct 27, 2023:   1:25